NEOGENOMICS, INC. (NEO) Shareholders’ equity 2016–2025
NEOGENOMICS, INC. (NEO) shareholders’ equity at each fiscal year-end, per SEC filings.
$836.6MFY2025 · since FY2016: $162.3M → $836.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $836.6M | -7.3% |
| FY2024 | $902.3M | -4.2% |
| FY2023 | $941.5M | -5.7% |
| FY2022 | $998.0M | -9.9% |
| FY2021 | $1.1B | +59.6% |
| FY2020 | $694.3M | +36.8% |
| FY2019 | $507.4M | +58.3% |
| FY2018 | $320.4M | +86.3% |
| FY2017 | $172.0M | +5.9% |
| FY2016 | $162.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice